Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry

J. Hagedoorn, A.H.W.M. Roijakkers

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

This chapter studies the role played by small entrepreneurial firms and large companies in the international biotechnology industry. The biotechnology industry is one of the main examples of current industries that are characterized by "hypercompetition" (D'Aveni, 1994), with a high degree of uncertainty about the combined effects of both new technologies and new market structures. It is an example of an industry with Schumpeterian competition where revolutionary changes in technology and innovative new products and processes have the potential to threaten the position of existing market leaders and their product-market positions (Liebeskind et al., 1996). It is also a sector where we find a large number of R&D alliances, in particular between large and small companies (Hagedoorn, 1996a; Kenney, 1986; Powell, 1996).Throughout this chapter we will refer to the biotechnology "industry" although, given the above-mentioned characteristics, this is probably an incorrect term as its status as a separate industrial sector is still somewhat unclear. Strictly taken, biotechnology is not yet a regular industrial sector but a hybrid form of an "industry" with established companies, e.g., from the pharmaceutical sector, and a wide range of new biotechnology companies that are science based and technology driven but still with relatively few regular products and limited manufacturing capabilities ... log in or subscribe to read full text
Original languageEnglish
Title of host publicationStrategic entrepreneurship: creating a new integrated mindset
EditorsM. Hitt, D. Ireland, M. Camp, D. Sexton
Place of PublicationLondon
PublisherWiley-Blackwell
Pages223-252
DOIs
Publication statusPublished - 2002

Fingerprint Dive into the research topics of 'Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry'. Together they form a unique fingerprint.

Cite this